Minireviews
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastrointest Endosc. Nov 16, 2014; 6(11): 541-548
Published online Nov 16, 2014. doi: 10.4253/wjge.v6.i11.541
Table 2 Guidelines of various societies on surveillance for colorectal cancer in ulcerative colitis
SocietyYearBeginning of surveillanceFrequencyTechniqueBiopsy protocolRiskChange
BSG2002All patients have colonoscopy screening at 8-10 yr; surveillance begins 8-10 yr after onset for pancolitis, 15-20 yr for left-sided colitisDecrease in surveillance interval with increase in disease duration for pancolitis:Every 3 yr: 2nd decadeEvery 2 yr: 3rd decadeEvery 1 yr: 4th decadeNil2-4 random biopsies every 10 cm from the entire colonPatients with PSC, including those with OLT, should have annual screening
AGA20048-10 yrEvery 1-2 yrNil
ACG20048-10 yrEvery 1-2 yrNil
ECCO20088 yr for pancolitis, 15 yr for left-sided colitisEvery 2 yr: 1st two decadesEvery 1 yr: 3rd decadeCE
BSG201010 yrBased on extent of disease, endoscopic and histologic activity, FH of CRC, presence of PSC, pseudopolyps, stricture, dysplasia on biopsy:Every 3 yr: low riskEvery 2 yr: intermediate riskEvery 1 yr: high riskCERandom biopsies every 10 cm and biopsies from raised/suspicious areas on CEPatients with PSC, including those with OLT, should have annual screeningIf dysplastic polyp within area of inflammation can be removed entirely, colectomy is not necessary
AGA20108-10 yrEvery 1-2 yrIf two examinations are negative, then every 1-3 yr up to 20 yr, then every 1-2/yrCEPatients with PSC, including those with OLT, should have annual screening
NICE201110 yrAs per BSG 2010 guidelinesCE
Australian20118-10 yrAs per BSG 2010 guidelinesCE
ECCO20136-8 yr, 8-10 yrSame as BSGCE